Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

RVNC Revance Therapeutics

Watchlist
33.130
-0.750-2.21%
Close  01/27 16:00 ET
33.1300.0000.00%
Post Mkt Price 01/27 16:07 ET
High
33.980
Open
33.370
Turnover
24.32M
Low
32.881
Pre Close
33.880
Volume
728.84K
Market Cap
2.73B
P/E(TTM)
Loss
52wk High
34.550
Shares
82.27M
P/E(Static)
Loss
52wk Low
11.270
Float Cap
2.44B
Bid/Ask %
0.00%
Historical High
42.410
Shs Float
73.80M
Volume Ratio
0.36
Historical Low
9.880
Dividend TTM
--
Div Yield TTM
--
P/B
18.71
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.99%
Amplitude
3.24%
Avg Price
33.361
Lot Size
1
Float Cap
2.44B
Bid/Ask %
0.00%
Historical High
42.410
Shs Float
73.80M
Volume Ratio
0.36
Historical Low
9.880
Dividend TTM
--
P/B
18.71
Dividend LFY
--
Turnover Ratio
0.99%
Amplitude
3.24%
Avg Price
33.361
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Nashville, TN.
CEO: Mr. Mark J. Foley
Market: NASDAQ
Listing Date: 02/06/2014
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist